Delayed tacrolimus-induced optic neuropathy

References

1. ↵
   1. Christians U,
   2. Jacobsen W,
   3. Benet LZ,
   4. Lampen A

   (2002) Mechanisms of clinically relevant drug interactions associated with tacrolimus. Clin Pharmacokinet 41, 813–851.
2. ↵
   1. Kessler L,
   2. Lucescu C,
   3. Pinget M,
   4. Charton MN,
   5. Mutschler V,
   6. Wolf P,
   7. et al.

   (2006) Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. Transplantation 81, 636–637.
3. 1. Brazis PW,
   2. Spivey JR,
   3. Bolling JP,
   4. Steers JL

   (2000) A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am J Ophthalmol 129, 536–538.
4. 1. Kapoor KG,
   2. Mirza SN,
   3. Gonzales JA,
   4. Gibran SK

   (2010) Visual loss associated with tacrolimus: case report and review of the literature. Cutan Ocul Toxicol 29, 137–139.
5. 1. Ascaso FJ,
   2. Mateo J,
   3. Huerva V,
   4. Cristóbal JA

   (2012) Unilateral tacrolimus-associated optic neuropathy after liver transplantation. Cutan Ocul Toxicol 31, 167–170.
6. ↵
   1. Venneti S,
   2. Moss HE,
   3. Levin MH,
   4. Vagefi MR,
   5. Brozena SC,
   6. Pruitt AA,
   7. et al.

   (2011) Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J Neurol Sci 301, 112–115.
7. ↵
   1. Rasool N,
   2. Boudreault K,
   3. Lessell S,
   4. Prasad S,
   5. Cestari DM

   (2018) Tacrolimus optic neuropathy. J Neuroophthalmol 38, 160–166.
8. ↵
   1. Devine SM,
   2. Newman NJ,
   3. Siegel JL,
   4. Joseph GJ,
   5. Geis TC,
   6. Schneider JA,
   7. et al.

   (1996) Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation. Bone marrow transplantation 18, 569–572.
9. ↵
   1. Shutter LA,
   2. Green JP,
   3. Newman NJ,
   4. Hooks MA,
   5. Gordon RD

   (1993) Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology 43, 2417–2418.
10. ↵
    1. Steg RE,
    2. Kessinger A,
    3. Wszolek ZK

    (1999) Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone marrow transplantation 23, 959–562.